Literature DB >> 12724434

Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine.

Henry Connor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12724434      PMCID： PMC539477          DOI： 10.1177/014107680309600508

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  7 in total

1.  Serotonin syndrome in a renal transplant patient.

Authors:  E H Wong; N N Chan; K H Sze; K H Or
Journal:  J R Soc Med       Date:  2002-06       Impact factor: 5.344

Review 2.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

3.  Serotonin syndrome and linezolid.

Authors:  Christine L Wigen; Matthew B Goetz
Journal:  Clin Infect Dis       Date:  2002-05-23       Impact factor: 9.079

Review 4.  Drug-drug interactions involving antidepressants: focus on venlafaxine.

Authors:  L Ereshefsky
Journal:  J Clin Psychopharmacol       Date:  1996-06       Impact factor: 3.153

5.  Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.

Authors:  Alexander A Fisher; Michael W Davis
Journal:  Ann Pharmacother       Date:  2002-01       Impact factor: 3.154

Review 6.  Serotonin syndrome. Presentation of 2 cases and review of the literature.

Authors:  P J Mason; V A Morris; T J Balcezak
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

7.  Serotonin syndrome due to venlafaxine overdose.

Authors:  R J Daniels
Journal:  J Accid Emerg Med       Date:  1998-09
  7 in total
  2 in total

1.  Clavulanic acid improves ethanol withdrawal symptoms in rats.

Authors:  Ehsan Mohebbi; Mehdi Molavi; Mohammad Mohammadzadeh; Hossein Hosseinzadeh; Bahareh Amin
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

2.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.